← FDA DRUG APPROVALS

FDA ANDA · ANDA071910

SODIUM IODIDE I 123

Sponsor: CURIUM

APPLICATION
ANDA071910
TYPE
ANDA
ORIGINAL APPROVAL
1989-02-28
LATEST ACTION
1993-06-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

SODIUM IODIDE I 123Prescription
SODIUM IODIDE I-123 200uCi · CAPSULE · ORAL

Approval history

1993-06-29Manufacturing (CMC) · Supplement 3AP
1991-03-18Manufacturing (CMC) · Supplement 1AP
1991-03-18Manufacturing (CMC) · Supplement 2AP
1989-02-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →